Research Topics
| Giovanni F M StrippoliSummaryCountry: Italy Publications
| Collaborators
|
Detail Information
Publications
Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progressionGiovanni F M Strippoli
National Health and Medical Research Council Centre for Clinical Research Excellence in Renal Medicine, University of Sydney, Australia
J Am Soc Nephrol 17:S153-5. 2006..On the basis of available RCT evidence, ACEi are the only agents with proven renal benefit in patients who have diabetes with no nephropathy and the only agents with proven survival benefit in patients who have diabetes with nephropathy...- Antihypertensive agents for primary prevention of diabetic nephropathyGiovanni F M Strippoli
Cochrane Renal Group, Centre for Kidney Research, Locked Bag 4001, Children s Hospital at Westmead, Westmead, NSW 2145, Australia
J Am Soc Nephrol 16:3081-91. 2005.... 
Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trialsLorna K Henderson
Cochrane Renal Group, Centre for Kidney Research, The Children s Hospital at Westmead, Sydney, Australia
Am J Kidney Dis 61:74-87. 2013..Treatment regimens combining cyclophosphamide with steroids preserve kidney function but have significant side effects. Newer immunosuppressive agents may have improved toxicity profiles...- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsElisabeth M Hodson
Centre for Kidney Research, The Children s Hospital at Westmead, Westmead, Australia
Cochrane Database Syst Rev 2:CD003774. 2013..This is an update of a review first published in 2005 and updated in 2008... 
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trialsGiovanni F M Strippoli
NHMRC Centre for Clinical Research Excellence in Renal Medicine, School of Public Health, University of Sydney, Australia
BMJ 336:645-51. 2008..To analyse the benefits and harms of statins in patients with chronic kidney disease (pre-dialysis, dialysis, and transplant populations)...- Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipientsGiovanni F M Strippoli
NHMRC Centre for Clinical Research Excellence in Renal Medicine, Centre for Kidney Research, The Children s Hospital at Westmead, Sydney, Australia
Transplantation 81:139-45. 2006..This study was conducted to evaluate the efficacy of preemptive treatment in preventing symptomatic CMV disease... - Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trialsGiovanni F M Strippoli
NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Locked Bag 4001, University of Sydney, Australia
J Am Soc Nephrol 15:2735-46. 2004.... - Fluid and nutrient intake and risk of chronic kidney diseaseGiovanni F M Strippoli
Centre for Kidney Research, NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, The Children s Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia
Nephrology (Carlton) 16:326-34. 2011..We evaluated the association between fluid and nutrient intake and chronic kidney disease (CKD)... - Haemoglobin targets: we were wrong, time to move onGiovanni F M Strippoli
Cochrane Renal Group and Centre for Kidney Research and NHMRC Centre for Clinical Research Excellence in Renal Medicine, School of Public Health, University of Sydney, Sydney, New South Wales, Australia
Lancet 369:346-50. 2007 - Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic reviewGiovanni F M Strippoli
NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Children s Hospital at Westmead, Westmead, NSW 2145, Australia
BMJ 329:828. 2004..To evaluate the effects of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor antagonists (AIIRAs) on renal outcomes and all cause mortality in patients with diabetic nephropathy... - Meta-analysis of biochemical and patient-level effects of calcimimetic therapyGiovanni F M Strippoli
NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, School of Public Health, University of Sydney, Australia
Am J Kidney Dis 47:715-26. 2006..We conducted a meta-analysis to evaluate outcomes of therapy with these novel agents... - Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trialsGiovanni F M Strippoli
Centre for Kidney Research, NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Locked Bag 4001, The Children s Hospital at Westmead and the University of Sydney, Westmead, NSW 2145, Australia
J Am Soc Nephrol 15:3154-65. 2004..There is insufficient data to guide decisions in patients without cardiovascular disease or in the predialysis population... - Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trialsGiovanni F M Strippoli
Centre for Kidney Research, National Health and Medical Research Council Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Children s Hospital at Westmead, University of Sydney, Sydney, Australia
Am J Kidney Dis 44:591-603. 2004..Oral, nasal, and topical antibiotic prophylaxis; exit-site disinfectants; and other antimicrobial interventions are used to prevent it. This study was conducted to assess what evidence supports these approaches... - Treatment for lupus nephritisLorna Henderson
Centre for Transplant and Renal Research, Westmead Millennium Institute, The University of Sydney at Westmead, Westmead, Australia
Cochrane Database Syst Rev 12:CD002922. 2012..Several new agents, including mycophenolate mofetil (MMF), suggest reduced toxicity with equivalent rates of remission. This is an update of a Cochrane review first published in 2004... - The number, quality, and coverage of randomized controlled trials in nephrologyGiovanni F M Strippoli
NHMRC Centre of Clinical Research Excellence in Renal Medicine, The Children s Hospital at Westmead, School of Public Health, University of Sydney, Australia
J Am Soc Nephrol 15:411-9. 2004.... - Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trialsElisabeth M Hodson
National Health and Medical Research Council Centre for Clinical Research Excellence, Centre for Kidney Research, The Children s Hospital at Westmead, Sydney, Australia
Lancet 365:2105-15. 2005..We undertook a systematic review to investigate whether this approach affects risks of cytomegalovirus disease and death... - Is renal impairment a predictor of the incidence of cataract or cataract surgery? Findings from a population-based studySon C Huynh
Centre for Vision Research, Department of Ophthalmology and Westmead Millennium Institute, University of Sydney, Sydney, NSW, Australia
Ophthalmology 112:293-300. 2005..To explore the relationship between creatinine clearance, an estimate of glomerular filtration rate, and 5-year incidence of cataract and cataract surgery... - Antihypertensive agents in patients with diabetes: trade-off between renal and cardiovascular protectionSankar D Navaneethan
Division of Nephrology, University of Rochester, 601 Elmwood Drive, Box 675, Rochester, NY 14642, USA
Diabetes Educ 32:596-602. 2006..Use of any agent that provides tight control of blood pressure is indicated in patients with diabetes but without nephropathy... - A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective studyCarlo Manno
Department of Emergency and Organ Transplantation, Renal, Dialysis and Transplant Unit, University of Bari, Bari, Italy
Am J Kidney Dis 49:763-75. 2007..We evaluated factors associated with long-term renal survival by using a novel simplified histological classification... - Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic studyMonica Franciosi
Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale, 66030 S Maria Imbaro CH, Italy
Clin J Am Soc Nephrol 2:984-91. 2007..The objective of this study was to investigate correlates of risk for having microalbuminuria in individuals with one or more cardiovascular risk factors... - Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trialsRobert S Flanc
Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
Am J Kidney Dis 43:197-208. 2004..In this systematic review of randomized controlled trials (RCTs), we assess the benefits and harm of current treatments for diffuse proliferative lupus nephritis (DPLN)... - The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trialAntonio Santoro
Nephrology, Dialysis, and Hypertension Department, Policlinico S Orsola Malpighi, Bologna, Italy
Am J Kidney Dis 52:507-18. 2008.... - Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trialsJoshua A Samuels
UT-Houston Health Science Center, Houston Texas, USA
Nephrology (Carlton) 9:177-85. 2004..43). Although the optimal management of patients with IgA nephropathy remains uncertain because of limitations with the existing published data, immunosuppressive agents are a promising strategy and should be investigated further... - Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trialsSuetonia C Palmer
Department of Nephrology, Christchurch Hospital, Christchurch, New Zealand
Am J Kidney Dis 45:638-49. 2005..This study was conducted to assess the evidence available to guide targeted treatment to reduce bone disease in transplant recipients... - Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic reviewKannaiyan S Rabindranath
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, UK
Am J Kidney Dis 45:437-47. 2005.... - An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticismGiovanni F M Strippoli
Department of Emergency and Organ Transplantation, Section of Nephrology, University of Bari, Bari, Italy
Am J Kidney Dis 41:1129-39. 2003..More properly designed and reported trials are necessary to reach a definitive assessment of this matter...